F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer


Gina Kolata and Rebecca Robbins
8/26/2026

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy....

Original

Tags: a | as | cancer | drug | in | key | long | that’s | the | to | trial



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top